<?xml version="1.0" encoding="UTF-8"?>
<p>In the face of the current pandemic, it is recommended to optimize coverage of healthy children and adults with influenza and pneumococcal vaccinations to mitigate the effects of community-acquired pneumonia.
 <xref rid="B27" ref-type="bibr">27</xref> The same vaccination strategy is strongly recommended for the majority of patients with autoimmune inflammatory rheumatic diseases prior to the administration of immunosuppressive therapy.
 <xref rid="B28" ref-type="bibr">28</xref> However, there are no studies suggesting the cross-resistance to SARS-CoV-2 in individuals vaccinated against influenza or pneumococcal pneumonia.
</p>
